Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: an economic analysis

Figure 4

A probabilistic scatter plot of the incremental cost-effectiveness ratio (ICER) between the Control and Gefitinib strategies for a cohort of 1,000 patients. Each dot represents the ICER for 1 simulation. An ellipse surrounds 95% of the estimates. Dots that are located below the ICER threshold represent cost-effective simulations for the active strategy compared with the Control strategy.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us